PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sclerosis

Novartis' Mayzent (siponimod) Receives EC's Approval to Treat Patients with Secondary Progressive Multiple Sclerosis with Active Disease

Novartis' Mayzent (siponimod) Receives EC's Approval to Treat Patients with Secondary Progressive Multiple Sclerosis with Active D...

January 21, 2020

Boehringer Ingelheim's Ofev (nintedanib) Receives FDA's Advisory Committee Recommendation for Systemic Sclerosis Associated ILD

Boehringer Ingelheim's Ofev (nintedanib) Receives FDA's Advisory Committee Recommendation for Systemic Sclerosis Associated ILD

July 26, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us